Skip to content
Averica
Speeding Discovery into Development
  • Services
    • Chiral Separation
    • Pharmaceutical Impurities
    • HPLC Method Development & Validation
    • Experimental Polar Surface Area (EPSA)
    • Physical Properties
    • GMP Testing
  • About Us
    • Technology
    • Testimonials
    • Careers
  • Resources
    • Events
    • Webinars
    • Blog
  • Blog
  • Contact Us
  • Twitter LinkedIn

Category: GMP

Journal of Chromatography – New Issue on Enantioseparations

October 5, 2016July 23, 2020 Averica Discovery Services, Inc.

Journal of Chromatography – New Issue on Enantioseparations October 5, 2016 Shout out for the new issue of the Journal… Read more

A Better Way To Look At Risk/Reward During Early Drug Development?

October 16, 2015July 23, 2020 Averica Discovery Services, Inc.

A Better Way to Look at Risk/Reward During Early Drug Development? Jeff Kiplinger October 16, 2015 How do you add… Read more

Averica Method Development

Method Development and Validation – Are We Doing It Right?

April 21, 2015July 23, 2020 Averica Discovery Services, Inc.

Method Development and Validation – Are We Doing It Right? April 21, 2015 Last year, a group of academic chromatographers… Read more

Averica Thalidomide

DeuteRx Research Stabilizing Thalidomide Enantiomers

March 10, 2015July 23, 2020 Averica Discovery Services, Inc.

DeuteRx Research Stabilizing Thalidomide Enantiomers March 10, 2015 Our recent post about the history of chiral drugs and the thalidomide… Read more

Looking at Impurity Isolation Early Can Benefit Your Drug Development Process

July 18, 2014July 23, 2020 Averica Discovery Services, Inc.

Looking at Impurity Isolation Early Can Benefit Your Drug Development Process July 18, 2014 Jeffrey Kiplinger, President and Founder of… Read more

Targeted Isolation of Impurities in Pharmaceutical Compounds using SFC

August 30, 2013July 23, 2020 Averica Discovery Services, Inc.

Targeted Isolation of Impurities in Pharmaceutical Compounds using SFC August 30, 2013 We presented two* posters at CoSMoS 2013, Targeted Isolation™ of… Read more

Benefits of Early Impurity Analysis to Pharmaceutical R&D

August 27, 2013July 23, 2020 Averica Discovery Services, Inc.

Benefits of Early Impurity Analysis to Pharmaceutical R&D August 27, 2013 We presented two/ posters at the CoSMoS 2013 (Conference… Read more

By Topic

View All
  • Chiral (15)
  • General (18)
  • GMP (7)
  • Impurities (14)
  • Method Development (14)
  • Physical Chemical Property (3)
  • Purification (11)

Solutions that fit your timeline and your budget!

Averica is the most efficient chromatography team.  Our specialized expertise gets you highly pure compound supply on-demand.

Contact Averica

Press Releases

No press releases found.

  • Services
    • Chiral Separation
    • HPLC Method Development & Validation
    • Pharmaceutical Impurities
    • Physical Properties
    • GMP Testing
  • Contact Us
  • Events
  • About Us
  • Technology
  • Careers
  • Testimonials
Twitter LinkedIn
Neopharm Labs Acquires Averica
455 Fortune Boulevard, Suite 2, Milford, MA 01757 | Phone: 508-757-4600 | sales@avericadiscovery.com
© 2023 | Averica Discovery Services Inc.